---
$id: https://graph.org.ai/products/commodity/51101934
$type: Product
source: UNSPSC
code: "51101934"
title: "Moxipraquine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxipraquine

**UNSPSC Code**: 51101934
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent with the molecular formula C24H38N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GP95SEQ1AQ, chemically known as 1-piperazinepropanol, 4-(6-((6-methoxy-8-quinolyl)amino)hexyl)-alpha-methyl- but generally known as moxipraquine, which bears US NIH Compound Identifier 72091. European Medicines Agency schedules Moxipraquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09088MIG. The term MOXIPRAQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). MOXIPRAQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moxipraquine under HS 29335995 and SITC 51576. As of Q4 2014, MOXIPRAQUINE remains the US FDA Preferred Term for this commodity. Moxipraquine bears US NLM identifiers UMLS ID C0611649 and NCI Concept Code C87633. SMILES: OC(CCN1CCN(CC1)CCCCCCNC1C2NCCCC2CC(OC)C1)C.

